Experience

Spectrus

• United States
• Research Services
• 1 - 100 Employee

• Spectrus Co-Founder & Chief Scientific Officer – Contract Research Organization for Biotech

  • Nov 2017 - Present

  100 Cummings Center Suite 420H, Beverly, MA-01915 Enrique is cofounder and Chief Scientific Officer at Spectrus. He serves clients through meticulous attention to the scientific questions at hand. Enrique applies his deep knowledge in protein chemistry and biochemical analysis to aid project design and deliver data to inform on decision making. ► About Spectrus ◄ As a CRO, Spectrus helps biotech companies accelerate discovery through mass spectrometry by providing deep expertise in method design, state-of-the-art instrumentation,… Show more Enrique is cofounder and Chief Scientific Officer at Spectrus. He serves clients through meticulous attention to the scientific questions at hand. Enrique applies his deep knowledge in protein chemistry and biochemical analysis to aid project design and deliver data to inform on decision making. ► About Spectrus ◄ As a CRO, Spectrus helps biotech companies accelerate discovery through mass spectrometry by providing deep expertise in method design, state-of-the-art instrumentation, and rigorous data analysis. Our team provides: ● Direct collaboration with lead scientists to design the appropriate method ● Accurate, cost-effective sample processing with rapid turnaround times ● Responsive communication throughout each project ● Clear and useful interpretation of the results to support data-driven decisions Quick Services Overview: ‘Omics and Biomolecule Characterization | Liquid Chromatography Mass Spectrometry (LCMS) | Project Consulting | Method Design | Analytical Chemistry | Sample Processing | Data Analysis | Reporting ► Our Vision and Mission ◄ Our vision is a world where scientific advances have resolved the most pressing health and environmental challenges of our era, securing a bright future and a better quality of life for all. Spectrus is committed to supporting biological research and innovation, leveraging the full capabilities of mass spectrometry to investigate and explore complex questions and transforming the way analytical data is generated and interpreted. ☛ Let’s explore your research project together: ✉ info@spectruscorp.com ☎ 510-827-1478 Specialties: CRO | medical research | protein biochemistry | protein expression | biophysics | proteomics | ‘omics | biotherapeutics characterization | protein & peptide discovery and quantitation | biomarkers discovery and validation | post translational modification analysis | target identification Show less



Momenta Pharmaceuticals

• United States
• Biotechnology Research
• 1 - 100 Employee

• Principal Scientist | Proteomics | Mass Spectrometry | Analytical Research | Predictive Modeling

  • Apr 2007 - Nov 2017

  Leader​ ​of​ ​the​ ​predictive​ ​modeling​ ​team​ ​for​ ​the​ ​discovery​ ​of​ ​disease​ ​and​ ​treatment biomarkers.​ ​Deep​ ​understanding​ ​of​ ​statistical​ ​techniques​ ​for​ ​the​ ​predictive modeling​ ​efforts. Leader​ ​of​ ​the​ ​proteomics​ ​platform​ ​that​ ​supported​ ​the​ ​drug​ ​discovery​ ​efforts. Head​ ​of​ ​the​ ​mass​ ​spectrometry​ ​group​ ​for​ ​eight​ ​years​ ​in​ ​the​ ​analytical​ ​research department.



Northeastern University

• United States
• Higher Education
• 700 & Above Employee

• Senior Research Scientist | Cancer Research | Biomarkers | Method Development

  • Jul 2005 - Apr 2007

  Biomarkers​ ​discovery​ ​from​ ​breast​ ​cancer​ ​tissue​ ​using​ ​mass​ ​spectrometry. Validation​ ​of​ ​biomarkers​ ​using​ ​label​ ​free​ ​quantitation​ ​LC-SRM/MRM. Method​ ​development​ ​for​ ​the​ ​study​ ​of​ ​glycoproteins​ ​using​ ​mass​ ​spectrometry.



Massachusetts General Hospital

• United States
• Hospitals and Health Care
• 700 & Above Employee

• PostDoc

  • Oct 2001 - Jul 2005



Harvard Medical School

• United States
• Higher Education
• 700 & Above Employee

• Postdoc

  • Oct 2001 - Jul 2005

  Greater Boston Area Expression,​ ​purification​ ​and​ ​biochemical​ ​characterization​ ​of​ ​the​ ​serotonin (5HT​3​R)​ ​receptor​ ​for​ ​pharmacological​ ​and​ ​structural​ ​studies. Discovered​ ​a​ ​novel​ ​transient​ ​binding​ ​site​ ​of​ ​anesthetics​ ​during​ ​the​ ​open​ ​state​ ​of ion​ ​channels​ ​using​ ​time-resolved​ ​photolabeling​ ​techniques. Identified​ ​the​ ​alcohol-binding​ ​site​ ​in​ ​the​ ​L1​ ​neural​ ​cell​ ​adhesion​ ​molecule​ ​using photoaffinity​ ​labeling​ ​and​ ​mass​… Show more Expression,​ ​purification​ ​and​ ​biochemical​ ​characterization​ ​of​ ​the​ ​serotonin (5HT​3​R)​ ​receptor​ ​for​ ​pharmacological​ ​and​ ​structural​ ​studies. Discovered​ ​a​ ​novel​ ​transient​ ​binding​ ​site​ ​of​ ​anesthetics​ ​during​ ​the​ ​open​ ​state​ ​of ion​ ​channels​ ​using​ ​time-resolved​ ​photolabeling​ ​techniques. Identified​ ​the​ ​alcohol-binding​ ​site​ ​in​ ​the​ ​L1​ ​neural​ ​cell​ ​adhesion​ ​molecule​ ​using photoaffinity​ ​labeling​ ​and​ ​mass​ ​spectrometry. Show less